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INTRODUCTION 
During pregnancy the rat mammary gland exhibits considerable de­
velopment involving branching of ducts and formation of alveoli, the 
secretory elements, at the ends of the ducts. This results primarily 
from stimulation by a combination of ovarian, pituitary, and adrenal 
hormones acting synergistically. At parturition the mammary gland under­
goes a rapid phase of morphological and functional differentiation. The 
number of cells per alveolus increases and the metabolic apparatus of 
the alveolar cells is extensively altered. This phase of mammary gland 
development, called "lactogenesis", was at one time thought to result 
from stimulation by a single lactogenic hormone--prolactin. Following 
isolation and purification of prolactin it was soon realized that in 
most mammals prolactin by itself is not a lactogenic hormone, but is part 
of a hormonal lactogenic complex in which prolactin, growth hormone, and 
the adrenal corticoids seem to dominate. The individual roles of the 
hormones involved in lactogenesis is as yet far from clear. The present 
series of experiments were designed to gain some information on the nature 
of these roles, 
Griffith and Turner (41) investigated the ability of hydrocortisone, 
prolactin, and growth hormone to induce an experimental "lactational" in­
crease in mammary gland cell numbers. They gave injections of estrogen 
and progesterone for twenty days to adult-virgin-ovariectomized rats in 
order to stimulate mammary development equivalent to that of late 
pregnancy and then injected hydrocortisone, prolactin, and growth hormone 
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in various combinations from days 21-23. Deoxyribonucleic acid content 
(DNA) was used as an index of mammary gland cell numbers (ug DNA/100 g 
body weight). They indicated that prolactin had no effect on DNA, but 
hydrocortisone and growth hormone increased DNA, 
The initial purpose of the present investigation was to duplicate 
this work of Griffith and Turner, except that ribonucleic acid (RNA) 
and nitrogen content would be estimated, as well as DNA. Thus, changes 
in functional activity of the mammary gland would be indicated along with 
alterations in cell numbers. 
Since the experiment of Griffith and Turner was criticized on the 
basis of the presence of endogenous pituitary hormones, it was decided 
to repeat the above experiment using rats hypophysectomized on day 21 
when the hydrocortisone, prolactin, and growth hormone treatments began. 
Early in the experiments there were indications that estrogen and 
progesterone might exert an inhibitory influence on lactational mammary 
gland development. Consequently, two final experiments were designed, 
similar to the two outlined above, in which estrogen and progesterone in­
jections were not terminated on day 20 but were continued along with the 
other hormonal treatments on days 21-23. It was hoped that these last 
two experiments would give significant information on the nature, extent, 
and site of this inhibition. 
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REVIEW OF LITERATURE 
The mammary gland serves the function of providing maternal nourish­
ment for the young for a varying period following birth. In its func­
tional lactating state, the mammary gland consists of a variable number 
of branching ducts radiating from the teat. Clusters of spherical 
"alveoli" are located on the sides and ends of the ducts. These clusters 
are referred to as "lobules." The alveoli are distended by milk se­
creted into their lumens from epithelial cells lining the alveoli. Myo­
epithelial cells surround the alveoli and, as a result of the stimulus 
of nursing, contract to squeeze milk from the alveoli into the ducts 
and finally out the teat. 
The mammary gland of the adult virgin female rat exists in a rela­
tively undeveloped state. With the onset of pregnancy, extensive growth 
and differentiation of the gland occurs before it reaches its functional 
state. All of these changes result from hormonal stimulation. Unfor­
tunately, however, no one hormone is capable of stimulating these altera­
tions by itself. Research has disclosed a complex interplay of hormones, 
in which nearly every hormone seemed to be directly or indirectly involved. 
Some of the major changes which occur in the mammary gland during 
pregnancy and lactation are graphically represented in Figure 1. A 
description of these changes and research concerning hormones involved 
with mammary development follows. 
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Figure 1. Morphological and functional development of the rat mammary 
gland during pregnancy and early lactation 
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Development of the Mammary Gland During Pregnancy 
and Lactation 
Structural developments 
The adult virgin rat has mammary glands which are characterized by 
the presence of a slender duct system spreading out from the base of the 
teat, usually with the entire absence of lobules and alveoli. Some 
slight development may occur during late stages of the estrus cycle, but 
this regresses with termination of that cycle (91). With the onset of 
pregnancy, the duct system begins to branch, and lobules composed of 
alveoli grow along the sides and ends of the ducts. Turner and Schultze 
(93) observed whole mounts of rat mammary glands and noted that the be­
ginning of lobule formation was present after 10 days of pregnancy and 
was essentially complete by day 15, This, together with several early 
cytological studies (77, 94), led to the belief that no new cell growth 
occurred after the first two-thirds of pregnancy. The increase in the 
size of mammary glands during the latter stage of pregnancy and during 
lactation was assumed to result from dilation of capillaries and dis­
tention of the alveoli as they became filled with secretions. However, 
more recent studies using DNA content of the mammary gland as an index 
of cell growth suggested that cell division continued throughout pregnancy 
and into early lactation (39, 42, 83, 84, 85). 
Greenbaum and Slater (39) first noticed that total DNA content of 
the gland doubled between the end of pregnancy and the third day of lac­
tation. Griffith and Turner (42), using DNA/100 g body weight as an 
index, found similar results. They indicated that between day 20 of 
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pregnancy and day 3 of lactation there was about a 40% DNA increase 
(Figure 1). Since DNA per mammary gland cell nucleus has been demon­
strated to remain constant (86), and connective tissue reported to 
change little during pregnancy and lactation (44), the observed rise in 
DNA suggested an increase in the number of mammary gland epithelial cells. 
This, of course, was in direct conflict with the previously long-held view 
that mammary growth was complete by day 15 of pregnancy. 
Lewin (54) found that the number of nuclei in mouse mammary glands 
increased significantly after parturition. Histological observations by 
Jeffers (47) and Munford (65) demonstrated that the number of cells lining 
individual alveoli increased during late pregnancy and early lactation. 
Greenbaum and Slater (39) suggested that a wave of cell division occurred 
after parturition. They reported some preliminary studies, utilizing 
colchicine to arrest mitosis, which indicated that a wave of cell division 
of short duration occurred 30 hours after parturition. They suggested 
that the short duration may explain the difficulty various investigators 
have had in observing this period of cell division. 
These observations revealed that branching of ducts and appearance 
of alveoli was completed by day 15 of pregnancy and that during late 
pregnancy there was a gradual increase in the number of cells per alveolus. 
Following parturition there seemed to be a rapid "wave" of cell division 
in the alveoli. 
Functional developments 
Following formation of a lobule-alveolar structure during the first 
two-thirds of pregnancy, cells lining the alveoli undergo a functional 
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differentiation from dormant cells to cells capable of synthesis and se­
cretion of milk. This involves formation and activation of a metabolic 
apparatus capable of synthesizing milk proteins from amino acids in the 
blood, transforming blood sugar into milk sugar, and forming fatty acids 
into milk fat. 
Early histological observations of developing rat mammary glands 
detected the presence of a fluid in the lumen of alveoli at about the 
middle of pregnancy (91). An abundant secretion was seen in ducts as well 
as alveoli from day 19 to the day of delivery. Under gross histological 
examination, lactating mammary glands did not appear much different from 
what was observed during late pregnancy. 
Recent ultrastructural studies have revealed a very interesting pic­
ture of cellular alterations which arise during the development of a fully 
lactating gland. Wellings (97) outlined seven distinct ultrastructural 
changes: 
1. Hypertrophy of granular endoplasmic reticulum 
2. Hypertrophy of the Golgi apparatus and appearance of protein 
droplets within enlarged Golgi vacuoles 
3. Movement of Golgi vacuoles to the cell surface and release of 
their contents 
4. "Pinching off" of large fat droplets from the cell surface 
into the lumen 
5. Increase in the number of cytoplasmic fat droplets, generally 
smaller than those observed in late pregnancy 
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6. Increase in the number of microvilli on the cell membrane 
lining the lumen 
7. Increase in the number of mitochondria, 
Hollman (45) quantitatively measured changes in mitochondrion volume, 
ergastoplasmic surface, and components of the Golgi system. The latter 
two cellular components exhibited a considerable increase in development 
during the first days of lactation, Hollman concluded that mammary gland 
cells were not fully differentiated until after parturition. 
Biochemical alterations observed in developing mammary glands also 
clearly seemed to indicate that not until after parturition does the rat 
mammary gland have a metabolic system necessary for sustained and copious 
secretions of milk capable of nourishing a normal litter of pups. One 
of the most dramatic changes which occurs in the rat mammary gland follow­
ing parturition is the alteration in respiratory metabolism, Folley (31) 
measured changes in -QOg and R.Q. in slices of mammary glands removed 
from rats during pregnancy and lactation; he noted an abrupt increase in 
both following parturition (Figure 1). The increase in oxygen consumption 
reflected the need for energy in synthesis of milk. The R.Q. was inter­
esting since it jumped up to 1.0 at the day of parturition, indicating in­
creased oxidation of glucose. In addition, it quickly rose above 1,0 
to 1.62 at day 8 of lactation. Folley explained that this rise above 
unity occurred because of a rapid synthesis of lipids from glucose or 
acetate. Popjak £t (72) demonstrated, in fact, that the transfer 
of from acetate to short-chained fatty acids sharply increased about 
10-fold at parturition. 
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Another change following parturition is activation of the hexose 
monophosphate shunt (18). More than 50% of the glucose utilized pro­
ceeds by way of this route, providing NADPH2 needed for fat synthesis. 
RNA content, nitrogen content, and enzyme levels all seem to follow 
a similar characteristic pattern—a gradual increase throughout pregnancy, 
followed by a dramatic rise during early lactation (Figure 1). RNA/DNA 
ratios, indicative of the amount of RNA per ceil, increase very little 
during pregnancy. However, from day 20 to day 3 of lactation there is 
about a 100% increase in cellular RNA content (84). The increase in RNA 
is correlated with an increase in total nitrogen--both of which reflect 
increased synthesis of milk proteins. Comparing RNA levels in the mammary 
gland during pregnancy with RNA levels found in the liver, Greenbaum and 
Slater (39) noted that the mammary gland had over twice as much RNA. 
Consequently, they explained that the transition which occurred at par­
turition was not one of an RNA deficient gland to an RNA rich one but of 
one already rich in RNA to one "extremely" rich in cellular RNA. 
Many studies have been concerned with changes in the activity of 
intracellular enzymes of rat mammary glands during pregnancy and lacta­
tion. Baldwin and Milligan (9) measured activities of mammary gland en­
zymes from rats at various stages of pregnancy and lactation. They 
studied 20 different enzymes representing the major metabolic pathways. 
Almost all enzymes increased in activity in approximately the same manner— 
a minor gradual increase during pregnancy and a major rise during the 
three days following lactation. A typical pattern of enzyme development 
is shown in Figure 1. Following parturition, there is also the develop-
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ment of new synthetic pathways, such as those concerned with the syn­
thesis of lactose (52). Also, as was previously pointed out, enzymes 
concerned with the hexose monophosphate shunt become active at a greatly 
increased rate. Kronfeld (50), however, offered a very astute point 
about these kinds of enzyme studies. He explained that vitro assays 
of enzyme "activities" in tissue homogenates actually measured the amount 
of an enzyme rather than its actual ^  vivo activity in a metabolic path­
way. In other words, these experiments described the machinery present 
in the mammary gland but did not demonstrate changes in the rates at 
which the component enzymes operate under different conditions, such as 
after nursing. 
Hormonal Control of Mammary Gland Growth During Pregnancy--
In Vivo Studies 
Ovarian hormones 
The first evidence that development of the mammary glands was under 
control of the endocrine system came from a series of early experiments 
(91) in which all nervous connections to the gland were removed. The 
mammary glands continued to grow during pregnancy and lactate as normal 
following parturition. Mammary glands transplanted to the ears of preg­
nant guinea pigs and rabbits were observed to develop during pregnancy 
and lactate at parturition (91). From these studies it became clear 
that something transported by the blood was the source of stimulation for 
mammary gland development. 
It had been known that changes in the mammary gland were correlated 
with changes in the ovary. Therefore, the ovary was the first organ in 
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which investigators searched for a source of the mammogenic substance. 
A complete account of these early experiments, which used various ovarian 
extracts to induce mammary growth, was described by Turner (91). These 
investigations found that estrogen injected into ovariectomized rats 
caused branching and extension of the duct system. Progesterone, by 
itself, had little effect on the mammary gland. However, when estrogen 
was given along with progesterone to ovariectomized rats, both duct 
growth and lobule-alveolar growth occurred. 
The ratio of estrogen to progesterone which produces maximal rat 
mammary gland development is interesting. Using DNA/100 g body weight 
as an index of mammary growth, the ratio of estrogen to progesterone 
which works best was determined to be 1:3000 (2, 3, 40, 64). 
Pituitary hormones 
It was observed that if the pituitary was removed the mammogenic 
effect of estrogen and progesterone was absent (53). Turner proposed a 
short-lived theory that the function of estrogen and progesterone was to 
cause release of specific pituitary hormones which were the true mammo­
genic hormones (58). However, no pituitary hormones have ever been shown 
to be able to stimulate full mammary gland development by themselves. 
Lyons et al. (57) conducted a classical series of experiments on the 
effects of hormones on mammary gland development in ovariectomized-
hypophysectomized rats. They found that if estrogen and progesterone 
were administered along with two pituitary hormones, prolactin and growth 
hormone, lobule-alveolar growth was stimulated. Consequently, it is 
generally accepted today that normal mammogenesis is dominated by a 
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synergism between ovarian and pituitary hormones. 
Adrenal hormones 
Lyons and his colleagues (57) also noted that if ovariectomized-
hypophysectomized rate were adrenalectomized, a glucocorticoid must be 
added to the hormonal complex of estrogen, progesterone, prolactin, and 
growth hormone to achieve the same degree of growth. While these re­
sults seemed to demonstrate the importance of glucocorticoids for normal 
mammary gland growth, the literature is filled with a large number of 
confusing and conflicting reports concerning the role of these adrenal 
hormones in normal mammary growth. As a consequence of a series of ex­
periments, Ahren and Jacobsohn(l) outlined reasons for the divergence 
of results: 
1. If the metabolic actions of glucocorticoids are not counter­
acted, normal mammary growth is inhibited. 
2. If the mammary growth-promoting actions of other hormones are 
reduced or eliminated, glucocorticoids provoke an abnormal 
growth. 
3. Under conditions optimal for mammogenesis and the maintenance 
of homeostasis, glucocorticoids enhance alveolar growth. 
Thyroxin and insulin 
Experiments concerning the possible role of thyroxin were also con­
flicting. However, Chen e^ al. (14) promoted considerable mammary growth 
in hypophysectomized-adrenalectomized-thyroidectomized rats with only 
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estrogen, progesterone, prolactin, growth hormone, and Cortisol. The 
absence of thyroxin from this complement of hormones indicated that 
whatever role thyroxin may normally have played in mammogenesis was ap­
parently minimal. 
Ahren and Jacobsdhn (2) produced some very interesting results con­
cerning the effects of insulin on mammogenesis. Giving long-acting 
insulin along with estrogen and progesterone to hypophysectomized-
gonadectomized rats, they produced considerable mammary gland growth. 
In other words, insulin seemed to substitute to some extent for prolactin 
and growth hormone. Whether this represented a pharmacological action 
of the doses of insulin used, or indicated a very real role for insulin 
has not been established by ^  vivo experiments. 
As a result of these studies, it is possible to make a generalized 
conclusion that mammary development results from the synergistic action 
of a quintet of hormones; estrogen, progesterone, prolactin, growth 
hormone, and glucocorticoids. While the hormones involved are defined, 
the nature of their synergistic roles is far from clear. Only when the 
actions of each of these hormones can be understood in terms of specific 
intracellular biochemical events, will we then be able to better describe 
the nature of this synergism. 
More extensive reviews on hormonal development of the mammary gland 
during pregnancy are given by Cowie and Folley (19), Kon and Cowie 
(49), Meites (58a), Folley (27), and Lyons, Li, and Johnson (57). 
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Hormonal Control of the Initiation of Lactation at 
Parturition—Vivo Studies 
The term "lactation" is often loosely used to describe various 
stages of the secretory activity of the mammary gland. While it is true 
that mammary glands show some secretory activity during late pregnancy 
and that a few mammals like the cow can be milked before parturition, 
nevertheless, in rats as in most mammals parturition marks the beginning 
of rapid morphological and biochemical changes which are necessary for 
the normal copious secretion of milk. This phase of lactation will be 
referred to as "lactogenesis" in this discussion. The term "galacto-
poiesis" is meant to indicate the maintenance of secretion or the enhance­
ment of secretion after the completion of lactogenesis. 
In 1928 Grueter conducted experiments aimed at determining the ef­
fects of anterior pituitary extracts on ovaries and secondary sex organs 
(43). Rabbits, pseudo-pregnant for 10 days, were injected for 5 days 
with anterior pituitary extracts and then killed on day 18. Not only 
did the extracts stimulate the ovaries and secondary sex organs, but an 
abundant secretion of milk was seen in the mammary glands. Strieker and 
Grueter repeated this experiment, except that the ovaries were removed 
at the 10th day when the pituitary extract was given (80). These animals 
also showed an abundant secretion. This suggested that some component 
in the pituitary extract had a lactogenic effect which appeared to act 
directly on the mammary gland rather than indirectly through the ovary. 
Using crude pituitary extracts, Strieker and Grueter, and others found 
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sliiill.ir results in oLhar species of mammals (15, 71, 92). 
RLcldle 2L (7b) observed that the anterior pituitary factor which 
caused developed mammary glands to lactate also caused the crop sac of 
pigeons to enlarge. Using this as an assay, they succeeded in isolating 
and purifying the auterior pituitary substance, which they called 
"prolactin" (75). 
Lyons (57) performed a rather dramatic experiment in which partially 
purified prolactin was injected directly into mammary gland ducts of 
pseudo-pregnant rabbits. Those sections of the mammary gland which came 
in contact with the prolactin were clearly seen to contain milk, while 
adjacent areas showed no secretion. This demonstration, which has been 
confirmed by others (11, 59), gave credence to the concept that at par­
turition there was a release of prolactin from the pituitary which exerted 
a direct stimulation on the mammary gland to initiate the entire process 
of lactation. Bolstering this hypothesis were studies concerning pro­
lactin secretion during pregnancy and lactation (46, 73, 74, 96), which 
demonstrated a relative constant prolactin secretion during pregnancy 
and a marked rise at parturition. Thus, the endocrine control of lactation 
appeared to be a nice, simple, straightforward process. Unfortunately, as 
often happens in endocrine studies, continued research discovered that 
the process was neither simple nor straightforward. 
The first indication of trouble with this theory came when it was 
observed that while crude anterior extracts readily initiated milk secretion 
in hypophysectomized rats possessing the necessary mammary development, 
partially purified prolactin did not. The conclusion drawn from these 
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observations was that other pituitary substances besides prolactin were 
necessary. The success of the intraduct injections of partially puri­
fied prolactin by Lyons and others has been explained on the basis of 
the fact that their animals were not hypophysectomized (57), Consequent­
ly, the animals had both endogenous pituitary secretions and exogenous 
prolactin in their blood. It was shown that if either adrencorticotrophin 
(ACTH) or cortisone was given with partially purified prolactin, lacta­
tion could be initiated in hypophysectomized animals (70). On the basis 
of these results, Folley and Young (33, 34) put forth the concept that 
lactogenesis does not result from stimulation of any one "lactogenic" 
hormone but, instead, results from a "lactogenic complex" of hormones 
consisting of prolactin, ACTH, and perhaps other pituitary secretions. 
The investigations of Lyons and his colleagues (57) served to emphasize 
the theory of a "lactogenic complex." They reported an initiation of 
lactation in hypophysectomized-ovariectoraized virgin rats (in which they 
experimentally developed mammary growth) with a complex of prolactin, 
growth hormone, and ACTH or cortisone. 
While the idea of a lactogenic complex is generally accepted, recent 
studies by Cowie (17) demonstrated that the rabbit was an exception. He 
indicated that milk secretion can be initiated in the rabbit by a single 
hormone. Rabbits with suitably developed mammary glands were adrenalec-
tomized, ovariectomized, and then injected with prolactin. The rabbits, 
virtually dying of adrenal insufficiency, lactated in response to the 
prolactin treatment. This illustrated the problem of species difference 
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which still plagues most endocrine investigations. 
With the development of the lactogenic complex hypothesis, the 
question which immediately followed was—what was the role of each hormone 
in the complex? Various biochemical studies were initiated in an attempt 
to shed some light on this question. Denamur investigated the effect of 
the lactogenic complex on RNA metabolism, Denamur and Gaye (24) 
hypophysectomized rats on the fifth day of lactation and, following the 
cessation of milk secretion, gave hormonal supplementation; prolactin, 
or prolactin + hydrocortisone, or prolactin+hydrocortisone + growth 
hormone + oxytocin. Five days after hypophysectomy, the total EINA of 
the control rats dropped from 12 mg to 2 mg. Prolactin by itself had no 
effect on this low RNA level. When given prolactin + hydrocortisone or 
the full combination of hormones, only a slight effect on RNA was observed; 
3 mg and 5 mg, respectively. Interpretation of this kind of experimental 
design requires certain necessary considerations; 1. Does arresting a 
fully lactating mammary gland and hormonally stimulating it to secrete 
again represent the same situation as normal lactogenesis at parturition? 
2. Does the RNA observed with hormone treatment reflect a stimulation 
of RNA metabolism, or does it indicate a retarding of RNA degradation? 
Denamur and his colleagues produced much more impressive data con­
cerning the effect of prolactin on RNA metabolism in rabbits (21, 22, 23, 
24). They reported that prolactin stimulated considerable increases in 
RNA, increased the number of polyribosomes, and altered the sedimentation 
profile of these polyribosomes. However, it must be remembered that the 
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rabbit is different than other mammals. It is the only animal which has 
been shown to lactate in response to prolactin alone. Thus, these ex­
periments, while interesting and important, gave little information con­
cerning interaction of the hormones in the lactogenic complex. 
Griffith and Turner (41) investigated the individual, as well as 
combined, ability of prolactin, growth hormone, and hydrocortisone to 
stimulate the lactational rise in mammary gland DNA content. They gave 
virgin ovariectomized rats daily injections of estrogen and progesterone 
to develop mammary glands comparable to those of normal pregnancy. They 
then injected prolactin, hydrocortisone, and growth hormone (alone and 
in various combinations) for three days to induce a lactational-like 
increase in DNA content. It was found that prolactin alone had no effect. 
Hydrocortisone, alone or in combination with prolactin and growth hormone, 
did induce an increase in mammary gland DNA. The results also suggested 
that growth hormone given alone might stimulate DNA. Conclusions from 
these results, however, suffered from the fact that the animals were not 
hypophysectomized to eliminate the source of endogenous pituitary hormones. 
Baldwin and Martin (8) studied the effects of prolactin and Cortisol 
on rats hypophysectomized on the day of parturition. They measured 
changes in DNA, RNA, casein, cytoplasmic protein, and enzyme activities 
in mammary glands. The results were quite impressive. Hypophysectomy 
reduced DNA levels, but prolactin and prolactin + hydrocortisone gave 
significantly higher levels. RNA levels were also reduced by hypophy­
sectomy. Prolactin alone partially increased the level of RNA, while 
the combination of prolactin + hydrocortisone restored RNA to normal 
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lactatlng levels. Prolactin or the combination of prolactin + hydro­
cortisone stimulated the same degree of total protein synthesis, but only 
the combination of prolactin + Cortisol specifically supported normal 
rates of casein synthesis following hypophysectomy. Enzyme activities 
per mg of DNA were similar in all treatment groups, with the exception of 
glucose-6-phosphate dehydrogenase. This enzyme was "specifically enhanced" 
by the combination of prolactin and Cortisol. 
Investigations by Baldwin and his coworkers (5, 6, 7, 9) have led him 
to suggest that increases in enzyme activities observed at lactation were 
of two types; 
1. Enzymes not hormonally regulated—these enzymes inherently in­
creased following mitosis and showed no change in the ratio of 
enzyme activity to DNA. 
2. Enzymes hormonally regulated—these enzymes specifically in­
creased with respect to the ratio of enzyme activity to DNA 
in response to hormone treatment (glucose-6-phosphate dehydro­
genase, fatty acid synthetase, citrate cleavage enzyme, UDPG 
pyrophosphorylase). 
Hormonal Control of the Initiation of Lactation—^ Vitro Studies 
Balmain and Folley (10) studied respiration curves of mammary gland 
slices from 20-day pregnant rats in which prolactin, and/or cortisone, was 
added to the medium. Prolactin had absolutely no effect while cortisone 
induced a respiratory curve typical of secreting tissue. They interpreted 
this as further evidence of the importance of the ACTH-adrenal axis in 
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the initiation of lactation. However, the inability of prolactin and 
cortisone to exert any effect greater than that measured with cortisone 
alone was disappointing in light of the synergism implied by vivo studies. 
Juergens, Stockdale, Topper, Turkington, and associates (48, 55, 63, 
82, 87, 88, 89) conducted a series of experiments on the effects of hor­
mones on cultured mouse mammary gland expiants. Initially, they indicated 
that mammary gland expiants derived from 10-12 day pregnant mice underwent 
cellular proliferation, followed by evidence of casein synthesis, when 
cultured in a medium containing insulin + hydrocortisone + prolactin. 
They observed that the original cells had no capacity for synthesizing 
casein, only daughter cells exhibited this capability. This correlated 
well with vivo research which indicated that a wave of cell division was 
normally associated with the initiation of lactation. These experiments 
suggested that not only was a mitotic phase associated with lactation, but 
it was a necessary antecedent for casein synthesis. 
A hypothesis concerning the sequence of action of these three hormones 
evolved from the work of these investigators (55, 82). Insulin is re­
sponsible for initiating mitosis, and during the mitotic phase hydrocorti­
sone acts on daughter cells, primarily to induce formation of rough endo­
plasmic reticulum. Finally, prolactin with insulin elicits milk protein 
synthesis in competent daughter cells. In this last step, prolactin is 
thought to act before insulin. Prolactin is responsible for the synthesis 
of polypeptides destined to become milk phosphoproteins. Without insulin, 
the polypeptides are not phosphorylated. 
It should be noted, however, that the results of these experiments 
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do not entirely correlate wi tli ^  vivo research; for example, Baldwin and 
Martin (8) reported a hormone-induced RNA synthesis without an increase 
in DNA. This is perhaps why references to vivo work are conspicuously 
lacking in reports from this group. Denamur (22) cautioned that the 
functional life of cultured mammary cells was very short (30 hours) and 
that cells which multiplied vitro synthesized casein during a very 
limited time. Furthermore, Denamur pointed out that mammary cells which 
differentiated vivo ceased synthesizing casein and could not be re­
initiated with prolactin and insulin. Thus, while results from ûi vitro 
research seemed to provide us with a clear description of the synergism 
of the lactogenic complex, it would be wise to wait until further correla­
tion of other vivo and ^  vitro experiments before accepting their 
hypothesis too tenaciously. 
Control of the Timing of Lactogenesis 
Normally lactation does not occur in the rat until parturition. How­
ever, if abortion occurs during the last half of pregnancy, mammary se­
cretion is initiated (60). The question which arises then is—what is 
the mechanism by which milk secretion is held in abeyance until the end 
of pregnancy? Numerous reviews (16, 18, 28, 29, 30, 32, 35, 60) on the 
research and theories of the initiation of lactation have been put forward 
during the last 30 years. On the basis of this past research, Cowie (17) 
recently outlined four general theories on the inhibition of lactogenesis; 
1, Estrogen and/or progesterone prevents release of anterior 
pituitary hormones and/or exerts a direct inhibition upon the 
mammary gland to stimulation by the lactogenic complex. 
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2. Levels of biologically active corticoids are too low during 
pregnancy. 
3. The release of oxytocin associated with parturition stimu­
lates the release of prolactin. 
4. Sensory stimulation (nursing, sight-sound-smell of the newborn) 
acting via the central nervous system causes the release of 
prolactin. 
Some of the more pertinent research concerned with the first two concepts 
is described in more detail below. 
Effects of estrogen and progesterone 
Nelson (67, 68) found that estrogen inhibited the initiation of lac­
tation. In his work with guinea pigs he concluded that estrogen not only 
inhibited release of prolactin but had a direct inhibitory effect at the 
level of the mammary gland to the stimulatory effect of lactogenic hormones. 
Folley and Malpress (32) developed the "two threshold" concept, based on 
investigations with other animals. They contended that low circulating 
doses of estrogen stimulated the lactogenic function of the anterior 
pituitary, while high levels tended to inhibit lactation even in the 
absence of the ovary. More recently Bruce and Ramirez (12) demonstrated a 
direct inhibition of lactation by placing estrogen implants in mammary 
gland ducts of lactating rats. Implants in the pituitary had no inhibitory 
effect on lactation. However, this experiment dealt with established 
lactation and not lactogenesis. 
As a result of a large series of investigations, Meites and Turner 
(60, 61) developed a theory in which both estrogen and progesterone 
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controlled lactogenesis. They hypothesized that estrogen stimulated 
prolactin secretion but the latter's release was held in check by levels 
of progesterone present during pregnancy. At parturition progesterone 
levels fell more rapidly than estrogen, allowing estrogen to stimulate 
prolactin release and cause lactogenesis. 
In more recent work, Meites and Sgouris (58b) reported that estrogen 
and progesterone had a direct effect on the mammary gland to inhibit it 
from responding to stimulation from hormones of the lactogenic complex. 
Apparently, they considered this to be a more important mechanism of in­
hibition than the indirect effect on the anterior pituitary. Other in­
vestigators also concluded that the combination of estrogen and progesterone 
was a more potent inhibitor than estrogen or progesterone alone (29). 
Progesterone alone has been reported to inhibit lactation. Wickman 
and Davis (98) demonstrated that progesterone inhibited the rise in RNA 
and polysome formation normally observed following ovariectomy during late 
pregnancy. However, if progesterone was administered 16 hours after 
ovariectomy, this inhibition did not occur. Turkington and Hill (87) 
suggested a very specific inhibitory effect of progesterone. They explained 
that the lactose synthetase enzyme consisted of two components, one of 
them being a-lactalbumin, the milk protein. They demonstrated that pro­
gesterone inhibited a-lactalbumin formation, thus preventing lactose 
synthesis. 
From these experiments it was clear that ovarian steroids were involved 
in an inhibition of lactogenesis during pregnancy. However, the mechanisms 
involved are as yet far from clear. 
24 
Effect of adrenal corticoids 
In most animals the levels of unbound glucocorticoids remain low, 
and thus inactive, during most of pregnancy (81). Prior to parturition, 
a decrease in protein binding causes the liberation of active unbound 
corticoids. It has been suggested that the increased glucocorticoid ac­
tivity is of prime importance in the initiation of lactation (25, 81). 
In the rat, however, Gala and Westphal (35) found a different situation 
to exist. Glucocorticoids remained low during pregnancy with only a very 
slight increase prior to parturition, and no change in protein binding 
of corticoids was observed before parturition. Nevertheless, using thymus 
weights as an index of glucocorticoid activity, a marked increase in the 
metabolic effects of glucocorticoids was observed prior to parturition. 
Gala and Westphal suggested that some factor during late pregnancy markedly 
increased the "biological effectiveness" of glucocorticoids. They seemed 
to feel that estrogen levels during late pregnancy might somehow be in­
volved. This alteration of "biological effectiveness" might explain why 
pharmacologically high doses of cortisone (25 mg/day) have been reported 
to have no effect on normal gestation in the rat (20). In other words, 
hormonal conditions during pregnancy might inhibit the metabolic actions 
of the glucocorticoids responsible for lactogenesis, and with the change 
in the hormonal balance at parturition, this inhibition is removed and 
the corticoids permitted to stimulate lactation. 
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METHODS 
Treatment of Animals 
Mature virgin female rats of the Sprague-Dawley-Rolfsmeyer strain 
were housed in a temperature controlled (23°ct2°), artificially lighted 
room (8 A.M. to 10 P.M.). Wayne Lab Blox and water were provided ad 
libitum. 
Ovariectomized rats were given daily injections of estradiol benzoate 
and progesterone for 20 days to induce mammary gland development equiva­
lent to that found in rats during late pregnancy. Following this 20 day 
priming with estrogen-progesterone, rats were divided into 24 different 
groups for daily hormone treatment on days 21-23. These 24 groups repre­
sented the following areas of investigation; 
1. Control animals were studied to determine the effect of placebo 
injections and the length of the period of estrogen-progesterone 
injection. All controls were also compared with normal lactating 
mammary glands. 
2. The effect of hydrocortisone, prolactin, and growth hormone on 
mammary development was determined in rats with intact pituitaries. 
3. The effect of hydrocortisone, prolactin, and growth hormone on 
mammary development was investigated in rats hypophysectomized on 
day 20 of treatment. 
4. Same as 2 except estrogen-progesterone injections were continued 
to day 23 to determine possible inhibitory effects of estrogen-
progesterone. 
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5. Same as 3 except estrogen-progesterone injections were continued 
to day 23 to determine possible inhibitory effects of estrogen-
progesterone. 
Table 1 indicates the daily dosage of hormones, symbolic notation used in 
the following pages, the carrier media, and the volumes injected. Table 2 
outlines the specific treatment for each of the 24 groups. 
All experimental animals were killed by an overdose of ether on the 
24th day of treatment. The six abdominal-inquinal mammary glands were re­
moved and prepared for analysis of DNA, RNA, and nitrogen content. 
Freshly removed mammary glands were immediately defatted using two 
12-hour extractions with chloroform/methanol (2/1), followed by two 12-hour 
ether extractions. The lipid free tissue was dried, weighed, and ground 
to a fine powder in a Wiley mill. 
Table 1. Exogenous hormones used in experiments 
Hormone Symbolic notation Daily dose Carrier media Volume in-
Analysis of Mammary Gland Nucleic Acid and Nitrogen 
jected daily 
Estradiol 
benzoate 
E 2 ug 
— Corn oil 0.1. ml 
Progesterone P 6 mg 
Hydrocortisone 
acetate (Cortisol) 
C 250 ug Distilled water 0.1 ml 
suspension 
Prolactin (Lactogen) L 2 mg Saline 0.15 ml 
Growth hormone G 1.5 mg Saline 0.15 ml 
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Table 2, List of groups showing hormonal treatment received daily 
from day 21-23 
CONTROLS 
21 -killed on day 21 
23 -estrogen and progesterone given to day 23 
X - no treatment 
S - saline 
N - normal 3-day lactating rat 
ESTROGEN AND PROGESTERONE STOPPED DAY 20—PJTUITARY INTACT 
C - hydrocortisone 
L - prolactin 
G - growth hormone 
CP - hydrocortisone+prolactin 
CG - hydrocortisone+growth hormone 
CLG - hydrocortisone+prolactin+growth hormone 
ESTROGEN AND PROGESTERONE STOPPED DAY 20—HYPOPHYSECTOMIZED DAY 21 
X - no treatment 
C - hydrocortisone 
L - prolactin 
G - growth hormone 
CL - hydrocortisone+prolactin 
CG - hydrocortisone+growth hormone 
CLG - hydrocortison«+proiactin+growth hormone 
ESTROGEN AND PROGESTERONE CONTINUED TO DAY 23—PITUITARY INTACT 
C+EP - hydrocortisone+estrogen and progesterone 
L+EP - prolactin+estrogen and progesterone 
G+EP - growth hormone+estrogen and progesterone 
CLG+EP - hydrocortisone+prolactin+growth hormone+estrogen and progesterone 
ESTROGEN AND PROGESTERONE CONTINUED TO DAY 23—HYPOPHYSECTOMIZED DAY 21 
EP - estrogen and progesterone only 
CLG+EP - hydrocortisone+prolactin+growth hormone+estrogen and progesterone 
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DNA and RNA were extracted together from 25 rag samples of the dried 
fat-freed tissue (DFFT) with hot trichloroacetic acid, as described by 
Schneider (78), DNA content was estimated using Burton's diphenylamine 
method (13), and Mejbaum's orcinol procedure (62), as outlined by 
Schneider (79), was used for analysis of RNA content, 
DNA content of the mammary gland extracts was compared with stock 
solutions of hydrolyzed DNA and RNA standards, prepared as described by 
Webb and Levy (95). In order to more accurately establish the concentra­
tions of these standards, total phosphorus content was determined 
colorimetrically using the procedure of Fiske and Subbarow (26). 
Nitrogen was extracted from 5.0 mg samples of DFFT and analyzed 
using a Kjeldahl microdetermination method of Lang (51). 
All colorimetric determinations were made using a Beckman DB. A 
step-by-step outline of the methods for defatting and the extraction-
analysis of nucleic acids and nitrogen is found in the Appendix, 
Surgical Procedures 
All rats were bilaterally ovariectomized using ether as the anesthetic, 
A recovery period of about 5 days was provided before hormone treatment 
was initiated, 
Hypophysectomy was performed by the intra-auricular method using a 
stereotaxic device, the Hoffman-Reiter Hypophysectomizer, A small incision, 
about a quarter of an inch, was made above and below the ear canal to 
facilitate positioning of the head in the stereotaxic apparatus. To 
prevent infection, 50,000 units of penicillin G was given intramuscularly. 
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This was injected in two 0.25 ml doses, one in each thigh. Hypophy-
sectomized rats were given 5% glucose to drink. Ether was used as the 
anesthetic because of the advantage of a rapid recovery. Rats which bled 
excessively were not used. Completeness of removal of pituitary tissue 
was determined by checking serial sections of the - rial above the sela 
tursica. The entire procedure for removal, fixing. tioning, and 
staining of this tissue is presented in the Append! . 
Hormones Used 
Estradiol benzoate, progesterone, and hydrocortisone acetate were 
purchased from Nutritional Biochemicals Corporation. Prolactin and 
growth hormone were obtained as a gift from the National Institutes of 
Health (growth hormone-NIH-GH-s9, prolactin-NIH-P-s8). All of the hor­
mones were received in the form of a dry powder. The procedure for pre­
paring these hormones for injection is described in the Appendix. 
Analysis of Data 
Mammary gland size varies with the size of the rat. To eliminate 
this variable, ug DNA/100 g body weight was used as an index of mammary 
gland growth. This procedure has been shown to be a more accurate index 
of mammary gland growth than total DNA (40). 
In order to eliminate differences in RNA and nitrogen resulting from 
differences in mammary gland size, RNA and nitrogen were expressed as 
ratios to DNA—mg total RNA/mg total DNA and mg total nitrogen/mg total DNA. 
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Since the DNA content per mammary gland cell remains constant, it was 
assumed that any change in these ratios indicated a change in cellular 
RNA or nitrogen content. 
Statistical analysis of the data was performed by Dr. David Cox 
at the Iowa State University Statistical Laboratory. Several different 
tests were utilized. 
1. For the control groups a pooled variance was determined by 
calculation of a Hierarchial Analysis of Variance (AOV). 
From this a least significant difference (LSD) was determined 
and a limited number of comparisons performed. (When using 
an LSD, the number of comparisons that can be made is one less 
than the number of groups—i.e., with 5 groups only 4 compari­
sons are allowed.) 
2. For the other experimental groups 3 types of tests were employed; 
a Least Squares AOV to determine main effects and interactions, 
and LSD and t-tests to make comparisons between individual 
groups. 
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RESULTS 
The effects of all treatments on levels of RNA, DNA, and nitrogen 
are given in Table 3. In order to make the interpretation of these re­
sults easier, the data will be treated as five separate investigations as 
previously outlined in the methods section. For each investigation there 
will be three components; 
1. Text—A page or two of explanation of the major effects of 
treatments on DNA, RNA, and nitrogen. 
2. Bar graphs—The means are represented visually by three bar 
graphs, one for DNA, another for RNA, and a third for nitrogen. 
3. Statistical analysis—In investigations 1, 4, and 5 the statis­
tics are presented on one table at the end of the three bar 
graphs. In 2 and 3, the statistics for DNA immediately follow 
the bar graph for DNA. Similarly, the statistics for RNA and 
nitrogen immediately follow their respective bar graphs. 
Investigation 1—Comparison of Control Groups 
DNA content - ug DNA/lOOg body weight (Figure 2, Table 4ab) 
Comparison of all experimentally developed mammary glands with 
those from 3-day lactating rats showed quite clearly a greater mammary 
gland DNA content in the lactating rats resulting from normal lactational 
growth. Injecting EP for 21 days or 23 days produced no significant 
difference. When EP was terminated at day 20 and no treatment given for 
the next three days, DNA levels did not change. If a saline placebo 
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Table 3. Effects of daily hormonal treatment received from day 21-23, 
following 20 days of EP 
Treatment group No, Body wt. s^e.^ DFFT^ s,e. 
rats X g X (mg) x 
Controls 
1-21 (killed day 21) 18 263 6 633 17 
2-23 (EP given to day 23) ID 257 5 636 29 
3-x (no injections) 10 279 7 841 29 
4-s (saline) 10 258 3 854 44 
5-N (normal lactating) 7 258 10 950 68 
Pituitary intact 
6-C 10 248 4 1090 49 
7-L 9 266 6 895 38 
8—G 10 274 6 998 70 
9-CL 10 253 3 1047 52 
10-CG 10 275 8 1156 69 
11-CLG 10 266 5 1067 60 
Hypophysectomized day 21 
12-no injection 10 233 4 417 14 
13-C 10 230 5 509 40 
14-L 12 236 5 461 23 
15-G 7 236 4 449 16 
16-CL 7 233 6 462 22 
17-CG 9 234 7 474 29 
18-CLG 11 228 6 539 24 
Pituitary intact 
19-C+EP 10 266 8 736 33 
20-L+EP 8 261 6 698 51 
21-G+EP 10 264 5 699 20 
22-CLG+EP 8 274 5 836 35 
•pophysectomized day 21 
23-EP 10 238 3 451 21 
24-CLG+EP 6 246 7 559 18 
^s.e. = standard error 
^DFFT = dried fat-freed tissue 
Table 3. (Continued) 
Treatment DNA ug/ RNA ug/ Nitrogen 
group mg DFFT s.e. mg^DFFT s.e, ug/mg DFFT s.e. 
X X X  X X  X  
Controls 
1-21 33.64 0.48 29.07 1.27 93.11 2.78 
2-23 30,84 1.48 29.92 1.34 85.80 4.02 
3-X 27.32 0.85 25.88 1.13 86.10 3.31 
4-S 26.86 0.73 27.60 1.06 77.70 3.31 
5-N 26.51 0.74 54.74 2.32 76.14 3.21 
Pituitary intact 
6-C 23.06 0.59 29.35 0.93 89.70 2.34 
7-L 25.98 0.77 28.80 1.29 88.44 4.21 
8-G 25.40 1.28 27.91 1.17 80.30 2.88 
9-CL 22.72 0.85 29.28 0.99 78.40 2.60 
10-CG 23.98 1.17 31.22 0.99 79.30 1.86 
11-CLG 23.06 0.95 29.72 0.74 80.60 2.02 
Hypophysectomized day 21 
12-X 29.69 1.08 10.48 0.78 81.20 2.20 
13-C 25.18 1.87 12.12 1.39 76.80 6.05 
14-L 30.55 0.99 13.80 0.66 88.58 1.70 
15-G 30.17 0.96 12.23 0.65 82.28 1.89 
16-CL 33.89 1.17 19.69 0.87 92.14 4.14 
17-CG 31.24 0.89 15.38 0.84 84.11 2.26 
18-CLG 29.84 1.13 22.70 1.70 81.73 4.00 
Pituitary intact 
19-C4-EP 31.32 0.71 31.55 0.96 85.80 1.68 
20-L+EP 31.73 0.95 28.10 0.88 82.75 3.07 
21-G+EP 34.87 0.93 27.82 1.43 89.60 4.50 
22-CLG+EP 28.20 0.61 33.19 1.36 73.13 6.00 
Hypophysectomized day 21 
23-EP 28.36 1.38 13.35 0.70 87.20 4.84 
24-CLG+EP 27.55 1.36 20.00 1.40 81.67 3.49 
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Table 3. (Continued) 
Treatment Total Total Total 
group DNA mg s.e. RNA mg s.e. nitrogen s.e. 
X X X X mg X % 
Controls 
1-21 21.23 0.50 18.36 0.90 58.85 2.23 
2-23 19.26 0.43 18.83 0.78 53.80 1.84 
3-x 22.89 0.84 21.79 1.25 72.54 3.94 
4-s 22.72 0.83 23.78 1.94 65.35 2.23 
5-N 24.94 1.25 51.93 4.07 72.42 6.50 
Pituitary intact 
6-C 24.99 0.99 31.70 1.10 97.99 5.58 
7-L 23.10 0.65 25.82 1.61 78.96 4.28 
8-G 24.91 1.38 27.78 2.03 79.27 4.90 
9-CL 23.46 0.82 30.75 2.22 81.53 4.12 
10-CG 27.38 1.47 35.92 2.23 91.55 5.85 
11-CLG 24.29 1.15 31.51 1.45 86.32 5.85 
Hypophysectomized day 21 
12-x 12.39 0.66 4.40 0.43 33.84 1.45 
13-C 12.45 0.82 6.01 0.61 37.99 2.83 
L4-L 14.05 0..8 6.33 0.40 40.90 2.35 
15-G 13.50 0.53 5.46 0.30 36.91 1.52 
16-CL 15.64 0.79 9.09 0.55 42.91 3.36 
17-CG 14.77 0.91 7.42 0.83 39.77 2.44 
18-CLG 15.97 0.70 12.54 1.49 44.35 3.24 
Pituitary intact 
19-C+EP 23.00 1.02 23.29 1.44 63.00 2.96 
20-L+EP 22.09 1.62 19.75 1.78 57.22 3.48 
21-G+EP 24.44 1.06 19.59 1.39 62.30 2.65 
22-CLG+EP 23.63 1.24 27.80 1.69 60.48 4.52 
Hypophysectomized day 21 
23-EP 12.71 0.76 6.04 0.46 38.74 1.70 
24-CLGfEP 15.32 0.63 11.12 1.70 45.81 3.05 
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Table 3. (Continued) 
Treatment ug DNA/ RNA/ Nitrogen/ 
group 100 gbw^ s.e. DNA s.e. DNA s.e. 
X X X X X X 
Controls 
1-21 8.07 0.16 0.86 0.036 2.77 0.080 
2-23 7.53 0.24 0.98 0.036 2.82 0.151 
3-X 8.21 0.21 0.95 0.047 3.17 0.146 
4-S 8.80 0.26 1.04 0.058 2.90 0.118 
5-N 9.71 0.38 2.07 0.072 2.89 0.159 
Pituitary intact 
6—C 10.71 0.35 1.28 0.043 3.92 0.156 
7-L 8.67 0.13 1.12 0.058 3.41 0.138 
8—G 9.04 0.37 1.12 0.068 3.24 0.243 
9-CL 9.26 0.32 1.30 0.067 3.48 0.144 
10-CG 9.95 0.41 1.32 0.070 3.36 0.144 
11-CLG 9.14 0.36 1.30 0.052 3.54 0.137 
Hypophysectomized day 21 
12-X 5.33 0.27 0.35 0.016 2.76 0.120 
13-C 5.38 0.28 0.48 0.045 3.06 0.140 
14-L 5.95 0.31 0.45 0.016 2.94 0.129 
15-G 5.73 0.26 0.41 0.027 2.74 0.111 
16-CL 6.69 0.29 0.58 0.027 2.73 0.144 
17-CG 6.27 0.22 0.49 0.023 2.70 0.084 
18-CLG 7.02 0.33 0.79 0.083 2.79 0.178 
Pituitary intact 
19-C+EP 8.63 0.20 1.01 0.033 2.75 0.070 
20-L+EP 8.45 0.55 0.89 0.032 2.63 0.147 
21-G+EP 9.26 0.35 0.80 0.036 2.61 0.188 
22-CLG+EP 8.62 0.41 1.17 0.035 2.61 0.253 
Hypophysectomized day 21 
23-EP 5.34 0.30 0.47 0.016 3.12 0.198 
24-CLG4-EP 6.26 0.31 0.73 0.041 3.01 0.220 
^gbw = grams body weight 
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Figure 2. Mammary gland DNA levels (ug DNA/100 gbw) of control groups 
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Figure 3. Mammary gland RNA (rag RNA/rag DNA) levels of control groups 
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Figure 4. Mammary gland nitrogen (mg nitrogen/mg DNA) levels of control groups 
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Table 4a. Statistical comparison of control groups with normal 3 day-
lac tating rats using t-test (Figures 2, 3, and 4) 
Groups 
compared 
Difference 
between means 
Significance 
DNA (ug DNA/100 g body weight) 
N and 21 
N and 23 
N and X 
N and S 
1.64 
2.17 
1.50 
0.91 
* significant (P<0.001) 
* significant (P<0.001) 
* significant (P<0.001) 
* approaching significance 
(P<0.05) 
RNA (mg total RNA/mg total DNA) 
N and 21 
N and 23 
N and X 
N and S 
1.03 
1 .12  
1.09 
1 .21  
* significant (P<0.001) 
* significant (P<0.001) 
* significant (P<0.001) 
* significant (P<0.001) 
Nitrogen (mg total nitrogen/mg total DNA 
N and 21 
N and 23 
N and X 
N and S 
0.12 
0.07 
0.28 
0.01 
not significant 
not significant 
not significant 
not significant 
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Table 4b. Statistical comparison of means of control groups (Figures 2, 
3, and 4) using Least Significant Difference (LSD), sig­
nificance at 57o level 
Groups 
compared 
Difference 
between means 
Significance 
DNA (ug DNA/100 g body weight) 
21 and 23 0.54 
X and S 0.59 
X and 21 0.14 
S and 21 0.76 
not significant 
not significant 
not significant 
* significant 
RNA (mg total RNA/mg total DNA) 
21 and 23 
X and S 
X and 21 
S and 21 
0.12 
0.09 
0.09 
0.18 
not significant 
not significant 
not significant 
* significant 
Nitrogen (mg total nitrogen/mg total DNA) 
21 and 23 
X and S 
X and 21 
S and 21 
0.02 
0.27 
0.40 
0.12 
not significant 
not significant 
* significant 
not significant 
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was injected for three days following termination of EP, there was 
a significant increase in DNA. For this reason all effects of hormone 
treatment were compared with the saline control. In other words, 
to consider an effect to be real, the hormone treatment must have 
yielded a response greater than that which resulted from the saline 
placebo. 
RNA content —mg total RNA/mg total DNA (Figure 3, Table 4ab) 
The normal lactating gland had twice as much cellular RNA as any 
of controls. The saline control exhibited a slight but significant 
increase in RNA over the 21 day control. 
Nitrogen content-mg total nitrogen/mg DNA (Figure 4, Table 4ab) 
No significant difference was observed between any of the control 
groups, even when compared to a normal lactating gland. 
Investigation 2—Effect of Prolactin, Hydrocortisone, and 
Growth Hormone Given on Days 21-23 to Pituitary Intact Rats 
DNA content - ug DNA/100 g body weight (Figure 5, Tables 5-6) 
The analysis of variance (AOV) indicated only one main effect, an 
increase in mammary gland DNA due to hydrocortisone. When the experi­
mental groups were specifically compared to the saline control, only 
hydrocortisone alone or the combination of hydrocortisone + growth hormone 
induced an increase in DNA. Hydrocortisone appeared to lose its effect 
whenever combined with prolactin, but analysis of variance indicated no 
statistically significant interaction between the two hormones. It was 
notable that the greatest effect was with hydrocortisone alone. In 
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Figure 5. Effect of hormones on mammary gland DNA (ug DNA/100 gbw) from pituitary intact rats 
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Table 5. Statistical comparison of mean DNA content (ug DNA/100 g 
body weight) of mammary glands from pituitary intact rats 
receiving prolactin, hydrocortisone, and growth hormone 
(Figure 5) 
Groups Difference Significance and test used 
compared between means LSD (57o level) t-• test 
S and C 1.90 * significant 
S and L 0.13 not significant 
S and G 0.24 not significant 
S and CL 0.46 not significant 
S and CG 1.15 * significant 
S and CLG 0.35 not significant 
C and L 2.04 * significant (P<0,001) 
C and G 1.67 * significant (P<0.005) 
C and CL 1.45 * significant (P<0.01) 
C and CG 0.76 not significant 
C and CLG 1.57 * significant (P<0.01) 
L and G 0.37 not significant 
L and CL 0.59 not significant 
L and CG 1.28 * significant (P<0.01) 
L and CLG 0.47 not significant 
G and CL 0.22 not significant 
G and CG 0.91 not significant 
G and CLG 0.10 not significant 
CL and CG 0.69 not significant 
CL and CLG 0.12 not significant 
CG and CLG 0.81 not significant 
N and C 1.00 * significant (P<.0.05) 
N and CG 0.24 not significant 
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Table 6. Least-squares analysis of variance of DNA content of mammary 
glands from pituitary intact rats receiving injections of 
prolactin, hydrocortisone, and growth hormone (Figure 5) 
Source Degrees Sum of squares Mean squares F 
freedom 
Total 69 90.352648 
Total reduction 7 22.716538 3.245220 2.975 
MU-YM 1 2.017345 2.017345 1.849 
C 1 5.531820 5.531820 5.017* 
L 1 2.184533 2.184533 2.002 
G 1 0.032082 0.032082 0.029 
C X L 1 1.093420 1.093420 1.002 
C X G 11 0.307606 0.307606 0.284 
L X G 1 0.000037 0.000037 0.000 
Remainder 62 67.636110 1.090905 
^Indicates significance at 5°L level 
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fact, hydrocortisone alone induced more DNA than that measured in 
normal lactating rats. 
RNA content-mg total RNA/mg total DNA (Figure 6, Tables 7-8) 
While it was obvious that no experimental group contained mam­
mary RNA equivalent to that found in normal lactating rats, hydrocortisone 
alone or in combination, caused a statistically significant increase 
in RNA compared to the saline control. There was no difference be­
tween hydrocortisone and hydrocortisone in combination with prolactin 
and growth hormone. 
Nitrogen content-mg total nitrogen/mg total DNA (Figure 7, Tables 9-10) 
Analysis by t-test indicated that hydrocortisone given alone 
produced the greatest significant increase in nitrogen. However, 
AOV did not indicate a main effect for hydrocortisone, but detected 
a main effect for prolactin. The AOV also suggested a significant 
interaction when any two of the three hormones were injected together. 
Surprisingly, normal lactating mammary glands exhibited no 
greater nitrogen content than the saline control. 
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Figure 6. Effect of hormones on mammary gland RNA (mg total RNA/mg total DNA) from pituitary 
intact rats 
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Table 7, Statistical comparison of mean RNA content (mg total 
RNA/mg total DNA) of mammary glands from pituitary intact 
rats receiving prolactin, hydrocortisone and growth 
hormone (Figure 6) 
Groups 
compared 
Difference 
between means 
Significance and test used 
LSD (57o level) t-test 
S and C 0.24 * significant 
S and L 0.08 not significant 
S and G 0.08 not significant 
S and CL 0.26 * significant 
S and CG 0.28 * significant 
S and CLG 0.26 * significant 
C and L 0.16 not significant 
C and G 0.16 11 
C and CL 0.02 II 
C and CG 0.04 ft 
C and CLG 0.02 II 
L and G 0.00 11 
L and CL 0.18 11 
L and CG 0.20 II 
L and CLG 0.18 11 
G and CL 0.18 11 
G and CG 0.20 11 
G and CLG 0.18 11 
CL and CG 0.02 11 
CL and CLG 0.00 11 
CG and CLG 0.02 11 
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Table 8. Least squares analysis of variance of RNA content (mg total 
RNA/mg total DNA) of mammary glands from pituitary intact 
rats receiving injections of prolactin, hydrocortisone, 
and growth hormone (Figure 6) 
Source Degrees Sum of Mean F 
freedom squares squares 
Total 69 6.186995 
Total reduction 7 3.959387 0.565627 15.743 
MU-YM 1 1.633850 1.633850 45.474 
C 1 0.372504 0.372504 10.368** 
L 1 0.008061 0.008061 0.224 
G 1 0.017482 0.017482 0.487 
C X L 1 0.006122 0.006122 0.170 
C X G 1 0.003294 0.003294 0.092 
L X G 1 0.005241 0.005241 0.146 
Remainder 62 2.227608 0.035929 
Indicates significance at 1% level 
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Figure 7. Effect of hormones on mammary gland nitrogen (mg total nitrogen/mg total DMA) from 
pituitary intact rats 
Table 9, Statistical comparison of mean nitrogen content (mg total 
nitrogen/mg total DNA) of mammary glands from pituitary 
intact rats receiving prolactin, hydrocortisone, and growth 
hormone (Figure 7) 
Groups Difference Significance and test used 
compared between means LSD (5% level) t-test 
S and C 1.01 * significant 
S and L 0.51 * significant 
S and G 0.34 not significant 
S and CL 0.58 * significant 
S and CG 0.46 * significant 
S and CLG 0.64 * significant 
C and L 0.51 * significant (P<0.05) 
C and G 0.68 * significant (P<0,025) 
C and CL 0.44 not significant 
C and CG 0.56 * significant (P<0.05) 
C and CLG 0.38 not significant 
L and G 0.17 II 
L and CL 0.07 fl 
L and CG 0.05 11 
L and CLG 0.13 II 
G and CL 0.24 ft 
G and CG 0.12 II 
G and CLG 0.30 II 
CL and CG 0.12 II 
CL and CLG 0.06 II 
CG and CLG 0.18 fl 
N and S 0.03 II 
51 
Table 10. Least squares analysis of variance of nitrogen content 
(mg total nitrogen/mg total DNA) of mammary glands from 
pituitary intact rats receiving injections of prolactin, 
hydrocortisone, and growth hormone (Figure 7) 
Source Degrees Sum of Mean F 
freedom squares squares 
Total 69 31.012584 
Total reduction 7 17.031455 2.433065 10.790 
MU-YM 1 10.726885 10.726885 47.569 
C 1 0.087623 0.087623 0.389 
L 1 1.153107 1.153107 5.114* 
G 1 0.386603 0.386603 1.714 
C X L 1 2.181064 2.181064 9.672** 
C X G 1 2.010758 22.010758 8.917** 
L X G 1 0.950591 0.950591 4.215* 
Remainder 62 13.981129 0.225502 
^Indicates significance at 5% level 
**Indicates significance at 1% level 
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Investigation 3—Effect of Prolactin, Hydrocortisone, and Growth 
Hormone Given on Days 21-33 to Rats Hypophysectomized on Day 21 
DNA content-ug DNA/100 g body weight (Figure 8, Tables 11-12) 
AOV demonstrated main effects for both hydrocortisone and pro­
lactin. However, comparison of individual groups indicated that neither 
hydrocortisone alone nor prolactin alone resulted in a greater amount 
of mammary gland DNA than that of the no treatment control. The com­
bination of hydrocortisone and prolactin produced higher levels of DNA 
than in the control. The combination of hydrocortisone + prolactin + 
growth hormone resulted in no greater DNA than the combination of 
hydrocortisone and prolactin. Nevertheless, comparison by t-test did 
point out that the combination of hydrocortisone and growth hormone ef­
fected a greater DNA content than hydrocortisone or growth hormone alone. 
The largest DNA level, produced by the combination of all three hor­
mones, was still significantly smaller than the DNA of the 21 day intact 
pituitary control. Consequently, these differences in DNA levels repre­
sent differences in the rate of mammary gland regression and do not neces­
sarily suggest a stimulation of DNA synthesis. The same is true for any 
increase in RNA or nitrogen, 
RNA content-mg total RNA/mg total DNA (Figure 9, Tables 13-14) 
AOV indicated main effects for all three hormones and a positive in­
teraction for prolactin and growth hormone. Comparisons of individual 
groups by t-test suggested, however, that only hydrocortisone when given 
alone effected a higher RNA level than that of the no treatment control. 
The effect of prolactin and growth hormone required the presence of 
hydrocortisone. 
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8. Effect of hormones on mammary gland DNA (ug DNA/100 gbw) from hypophysectomized rats 
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Table 11. Statistical comparison of mean DNA content (ug DNA/100 g 
body weight) of mammary glands from hypophysectomized rats 
receiving prolactin, hydrocortisone, and growth hormone 
(Figure 8) 
Groups 
compared 
Difference 
between means 
Significance and 
LSD (5% level) 
test used 
t-test 
X and C 0.05 not significant 
X and L 0.62 not significant 
X and G 0.40 not significant 
X and CL 1.36 * significant 
X and GG 1.14 * significant 
X and CLG 1.69 * significant 
G and L 0.57 not significant 
G and G 0.35 not significant 
G and GL 1.31 * significant (P<0.01) 
G and GG 0.89 * significant (P< 0.05) 
G and GLG 1.64 * significant (P<0.001) 
L and G 0.22 not significant 
L and CL 0.74 II 
L and GG 0.32 II 
L and GLG 0.07 II 
G and GL 0.96 II 
G and GG 0.54 ft 
G and CLG 1.29 * significant (P<0.025) 
CL and GG 0.42 not significant 
GL and GLG 0.33 not significant 
GG and GLG 0.75 * approaching significance 
(P<L0.05) 
21 and XLG 1.05 * significant (P<0.001) 
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Table 12, Least squares analysis of variance of DNA content (ug 
DNA/100 g body weight) of mammary glands from hypophy-
sectomized rats receiving injections of prolactin, 
hydrocortisone, and growth hormone (Figure 8) 
Source Degrees Sum of Mean F 
freedom squares squares 
Total 66 647.265731 
Total reduction 7 599.261615 85.608802 105.218 
MU-YM 1 340.738260 340.738260 418.788 
C 1 3.465351 3.465351 4.259* 
L 1 4.801319 4.801319 5.901* 
G 1 1.071697 1.071697 1.317 
C X L 1 1.161514 1.161514 1.428 
C X G 1 0.525461 0.525461 0.646 
L X G 1 0.720130 0.720130 0.885 
Remainder 59 48.004116 0.813629 
*Indicates significance at the 5% level 
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Figure 9, Effect of hormones on mammary gland RNA (mg total RNA/mg total DNA) from 
hypophysectomized rats 
57 
Table 13. Statistical comparison of RNA content (mg total RNA/mg 
total DNA) of mammary glands from hypophysectomized rats 
receiving prolactin, hydrocortisone, and growth hormone 
(Figure 9) 
Groups Difference Significance and test used 
compared between means LSD (57o level) t-•test 
X and C 0.13 * significant 
X and L 0.10 not significant 
X and G 0.06 not significant 
X and CL 0.23 * significant 
X and CG 0.14 * significant 
X and CLG 0.44 * significant 
C and L 0.03 not significant 
C and G 0.07 * significant (P<0.05) 
C and G 0.07 * significant (P<0.05) 
C and CL 0.10 * significant (PCO.Ol) 
G and CG 0.01 not significant 
C and CLG 0.31 * significant (P<.0.01) 
L and G 0.04 not significant 
L and CL 0.13 * significant (P< 0.005) 
L and CG 0.04 not significant 
L and CLG 0.34 * significant (P< 0.001) 
G and CL 0.17 * significant (P<0.005) 
G and CG 0.08 not significant 
G and CLG 0.38 * significant (P<0.005) 
CL and CG 0.09 iV significant (P<0.005) 
CL and CLG 0.21 not significant 
CG and CLG 0.30 * significant (P<0.01) 
21 and CLG 0.07 * significant (P<0.001) 
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Table 14. Least squares analysis of variance of RNA content (mg 
total RNA/mg total DNA) of mammary glands from hypophy-
sectomized rats receiving injections of prolactin, 
hydrocortisone, and growth hormone (Figure 9) 
Source Degrees Sum of Mean 
freedom squares squares F 
Total 66 18.089909 
Total reduction 7 17.004825 2.42961 132.088 
MU-YM 1 8.444837 8.444837 459.177 
C 1 0.097793 0.097793 5.317* 
L 1 0.389676 0.389676 21.188** 
G 1 0.134887 0.134887 7.334** 
C X L 1 0.000009 0.000009 0.000 
C X G 1 0.005360 0.005360 0.291 
L X G 1 0.077766 0.077766 4.228* 
remainder 59 1.085081 1.085081 
^Indicates significance at the 5% level 
**Indicates significance at the 1% level 
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Figure 10. Effect of hormones on mammary gland nitrogen (mg total nitrogen/mg total DNA) from 
hypophysectomized rats 
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Table 15. Statistical comparison of nitrogen content (mg total 
nitrogen/mg total DNA.) of mammary glands from hypophy-
sectomized rats receiving prolactin, hydrocortisone, and 
growth hormone (Figure 10) 
Groups 
compared 
Difference 
between means 
Significance and 
LSD (5% level) 
test used 
t-test 
X and C 0.30 not significant 
X and L 0.18 If 
X and G 0.02 tl 
X and CL 0.03 11 
X and CG 0.06 It 
X and CLG 0.03 tt not significant 
C and L 0.12 If 
C and G 0.32 II 
C and CL 0.33 tl 
C and CG 0.36 II 
C and CLG 0.27 ft 
L and G 0.20 11 
L and CL 0.21 II 
L and CG 0. 24 11 
L and CLG 0.15 II 
G and CL 0.01 II 
G and CG 0.04 II 
G and CLG 0.05 If 
CL and CG 0.03 II 
CL and CLG 0.06 If 
CG and CLG 0.09 If 
21 and CLG 0.02 II 
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Table 16. Least squares analysis of variance of nitrogen content 
(mg total nitrogen/mg total DNA) of mammary glands from 
hypophysectomized rats receiving injections of prolactin, 
hydrocortisone, and growth hormone (Figure 10) 
Source Degrees Sum of Mean F 
freedom squares squares 
Total 66 13.536425 
Total reduction 7 2.880992 0.411570 2.279 
MU-YM 1 0.513734 0.513734 2.845 
C 1 0.131127 0, i;''n 0.726 
L 1 0.176255 0.176233 0.976 
G 1 0.002258 0.002258 0.013 
C X L 1 0.603476 0.603476 3.341 
C X G 1 0.254609 0.254609 1.410 
L X G 1 0.385935 0.385935 2.137 
remainder 59 10.655434 0.180601 
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The highest RNA level, produced by the combination of all three 
hormones, was still significantly lower than the 21 day-intact pitui­
tary control. 
Nitrogen content-mg total nitrogen/mg total DNA (Figure 10, Tables 15-16) 
No effect was observed in any treatment group. 
Investigation 4—Effect of Administering Estrogen and Pro­
gesterone to Pituitary Intact Rats Receiving Prolactin, Hy­
drocortisone, and Growth Hormone 
DNA content-ug DNA/100 g body weight (Figure 11, Table 17) 
Estrogen and progesterone significantly inhibited the hydro­
cortisone induced increase in DNA. It also inhibited the increase in 
DNA resulting from the stress of placebo injections. 
RNA content-mg total RNA/mg total DNA (Figure 12, Table 17) 
Estrogen and progesterone significantly inhibited RNA content in 
all groups except the saline control. 
Nitrogen content-mg total nitrogen/mg total DNA (Figure 13, Table 17) 
Estrogen and progesterone significantly inhibited cellular nitro­
gen content in all groups except the saline control. 
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Table 17. Statistical comparison of means of pituitary intact rats 
receiving estrogen and progesterone with injections of 
prolactin, hydrocortisone, and growth hormone (Figures 
11, 12, and 13) 
Groups 
compared 
Difference 
between means 
t-test significance 
DNA (ug DNA/100 g body weight) 
S and 23 1.33 
C and C+EP 2.08 
L and L+EP 0.22 
G and G+EP 0.22 
CLG and CLG+-EP 0.52 
* significant (P<0.005) 
* significant (P<0,001) 
not significant 
not significant 
not significant 
RNA (mg total RNA/mg total DNA 
S and 23 0.06 
C and C+EP 0.27 
L and L+EP 0.23 
G and G+EP 0.32 
CLG and CLG+EP 0.23 
not significant 
* significant (P<0,001) 
* significant (P<0.005) 
* significant (P<0,001) 
* significant (P<0,C1) 
Nitrogen (mg total nitrogen/mg total DNA) 
S and 23 0.08 not significant 
C and C+EP 1.17 * significant (P<0.001) 
L and L+EP 0.78 * significant (P<0.005) 
G and GfEP 0.63 * significant (P<0.001) 
CLG and CLG+EP 0.93 * significant (P<0.01) 
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Investigation 5--Effect of Administering Estrogen and 
Progesterone to Hypophysectomized Rats Receiving Pro­
lactin, Hydrocortisone, and Growth Hormone (Figures 14, 
15, 16, Table 18) 
No significant inhibition of DNA, RNA, or nitrogen content was 
observed in the mammary glands of these rats. However, the hypophy­
sectomized group receiving only estrogen and progesterone had a sig­
nificantly higher DNA content than the hypophysectomized no-treatment 
control. 
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Figure 14, Effect of EP on hormonally induced mammary gland DNA (ug DNA/100 gbw) from 
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Figure 16. Effect of EP on hormonally induced mammary gland nitrogen (mg total nitrogen/mg total 
DNA) in hypophysectomized rats 
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Table 18. Statistical comparison of means of hypophysectomized rats 
receiving estrogen and progesterone with injections of 
prolactin, hydrocortisone, and growth hormone (Figures 14, 
15, and 16) 
Groups 
compared 
Difference 
between means 
t-test significance 
DNA (ug DNA/100 g body weight) 
X and EP 0.01 
CLG and CLG+EP 0.76 
not significant 
not significant 
RNA (mg total RNA/mg total DNA) 
X and EP 0.12 
CLG and CLG+EP 0.06 
significant (P<0.001) 
not significant 
Nitrogen (mg total nitrogen/mg total DNA) 
X and EP 0.36 not significant 
CLG and CLG+EP 0.32 not significant 
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DISCUSSION 
Comparison of control groups demonstrated that placebo injections 
induced an increase in DNA and RNA. Previous investigations of experi­
mental lactogenesis utilized a 20-day estrogen-progesterone injected 
group as a control. In light of this finding it is suggested that all 
future studies of this nature use placebo injected controls. 
In pituitary intact rats hydrocortisone clearly demonstrated an 
ability to induce a lactational-like rise in mammary gland DNA, RNA, 
and nitrogen content. Prolactin and growth hormone had essentially no 
effect. These results are offered as evidence for previous suggestions 
(81, 35) that the actual "trigger" for lactogenesis is not a sudden re­
lease of prolactin, but an increase in glucocorticoid activity on, or 
just prior to parturition. These results did not suggest that prolactin 
and growth hormone were unnecessary, but only that by increasing the 
amount of prolactin and growth hormone above endogenous levels, a lacto­
genic response was neither initiated nor potentiated. That pituitary 
hormones were, in fact, necessary for hydrocortisone to exert a lacto­
genic effect was indicated by results obtained from the hypophysectomized 
groups. 
Hydrocortisone had no effect in hypophysectomized rats on mammary 
gland DNA unless it was combined with growth hormone or prolactin. 
Baldwin and Martin (8) obtained similar results. They injected pro­
lactin and hydrocortisone into lactating rats hypophysectomized on the 
day of parturition and found that hydrocortisone alone had no effect on 
the regression of DNA content of the mammary glands, but a combination 
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of hydrocortisone + prolactin restored DNA levels to normal. Baldwin 
and Martin also reported that prolactin alone had an ability to partially 
retard mammary gland DNA regression. The AOV in our investigation also 
suggested an effect of prolactin in preventing DNA regression. 
The effect of hormone treatment on mammary gland RNA content in the 
hypophysectomized rats was different than the effect on DNA. Hydrocor­
tisone given alone did affect mammary gland RNA. Hydrocortisone treat­
ment produced a greater RNA content than the hypophysectomized-no 
treatment controls. In addition, either prolactin or growth hormone 
potentiated the effect of hydrocortisone on mammary RNA, but neither 
prolactin nor hydrocortisone had an effect when given alone. While it 
can be seen that for best results a combination of all three hormones 
was required, nevertheless, in both pituitary intact and hypophysec­
tomized rats only hydrocortisone exerted an effect when given alone. 
It was pointed out in the results section that any hormonal effect 
on mammary gland nucleic acids in the hypophysectomized rats did not 
necessarily reflect a stimulation of nucleic acid synthesis, but more 
likely represented a decrease in the rate of regression. Obviously some­
thing was lacking in the replacement therapy. Denamur (22) reported a 
similar inability to restore RNA levels back to normal in hypophysectomized 
rats. In contrast to findings in the present investigation and in Denamur's 
work, Baldwin and Martin (8) claimed to have restored both DNA and RNA 
levels back to normal with hydrocortisone and prolactin. Part of the 
explanation for their success might lie in the experimental design of 
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their work. The rats were supplied to Baldwin and Martin already 
hypophysectomized on the day of parturition by two different suppliers 
(Berkley Pacific or Simeson Laboratories). The animals were supposedly 
supplied 24 hours after parturition. The question is; how long follow­
ing parturition did the hypophysectomy occur? This experimental pro­
cedure did not really demonstrate an ability of prolactin and hydro­
cortisone to "initiate lactation", but rather to "maintain" an already 
initiated lactation. Furthermore, the completeness of hypophysectomy 
was checked by gross visual observation, rather than by histological 
procedures. 
Even in the pituitary intact rats, no combination of hormones pro­
duced levels of mammary gland EINA anywhere near what was determined for 
the normal lactating zat. This further illustrated the absence of some 
factor from the complex of hormones used to initiate lactation. It 
might simply have been that the dosage of the hormones was not adequate. 
Perhaps other hormones, e.g., insulin and/or thyroxin should have been 
added to the complex of hormones injected. The lack of a nursing stimu­
lus could well have been the missing element. Actually, in our laboratory 
we have tried giving pups to rats with experimentally developed mammary 
glands, and invariably they ate the pups. After many attempts one such 
rat did accept a litter of six pups and nursed them (unpublished research 
by Norman Grimes, Roy Bennett, and David R. Griffith). This provided 
evidence that mammary glands of virgin rats, developed by estrogen-
progesterone treatment, can lactate normally. The fact that so many of 
the "artificial" dams ate the pups also indicated that some factor was 
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definitely missing. 
While the normal lactating rats exhibited a lactational rise in 
mammary gland DNA and RNA content, little change was observed in the 
amount of nitrogen per cell, as estimated by the nitrogen/DNA ratio. 
One possible reason for the lower than expected nitrogen levels might 
have been the removal of milk from the mammary glands by the nursing pups. 
Previous research has established that estrogen and progesterone 
lave an inhibitory influence on the initiation of milk secretion (29). 
Our results confirmed this, but also demonstrated the extent of this 
inhibition. There was not just an inhibition of milk let down, or 
merely an inhibition of the synthesis and/or secretion of milk components, 
but rather there was a complete inhibition of the lactogenesis process. 
Mammary gland DNA, RNA, and nitrogen content remained unaffected by any 
combination of hormones which had previously been observed to have an 
effect. 
The most notable aspect of the inhibition of lactogenesis was the 
prevention of the lactational rise in DNA induced by hydrocortisone 
treatment. This particular finding revealed that the combination of 
estrogen and progesterone which has been reported to possess maximal 
mammary gland growth-promoting ability was also the inhibitor of lacta­
tional mammary growth. From this it may be inferred that the two phases 
of mammary gland cell proliferation, gestational growth and lactational 
growth, are controlled by two different cellular mechanisms; one mechanism 
being activated by estrogen and progesterone, and the other inhibited by 
the same two hormones. 
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Since estrogen and progesterone inhibited the lactogenic action of 
exogenous hormones, one might speculate that the site of inhibition was 
at the level of the mammary gland, Talwalker et al. (81) reported that 
a high dose of hydrocortisone (2 mg/day for 5 days) given to pregnant 
rats induced milk secretion. Ferreri and Griffith (25) repeated the 
experiment, except they used mammary gland DNA and RNA content as evi­
dence of a lactogenic response. They reported that no increase in 
nucleic acid occurred with hydrocortisone treatment during mid-pregnancy, 
and only a slight increase in RNA was observed when hydrocortisone was 
injected during late pregnancy. Thus, whereas in the present experiment 
a dose of 250 ug hydrocortisone gave a marked lactogenic effect, during 
pregnancy a dose as high as 2 mg was ineffective . As a 
possible explanation for the inability of hydrocortisone to induce lac­
tation, Ferreri and Griffith offered a suggestion previously made by 
Gala and Westphal (35), that some factor inhibits the metabolic action 
of hydrocortisone during pregnancy. On the basis of the results of the 
present investigation, it is suggested that the inhibition by estrogen 
and progesterone occurred by directly preventing the mammary gland from 
responding to the lactogenic effect of the glucorticoids. 
The results of the effect of estrogen and progesterone on the mammary 
glands of hypophysectomized rats was considered inconclusive due to a lack 
of statistical significance resulting from too few animals and a large 
variance. There seemed to be an indication that hormonally induced DNA 
was inhibited. 
One of the main features of the in vitro work with mouse mammary 
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explants (55) is that mitosis must occur before alveolar cells can lac­
tate. In previous experiments by Baldwin and Martin (8) and Ferreri 
and Griffith (25), as well as in the present investigation, increases in 
mammary gland RNA content have been demonstrated without an increase in 
DNA. 
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SUMMARY 
The present experimentation was concerned with the endocrine 
factors responsible for the initiation of lactation in the rat. Adult 
virgin female rats were given daily injections of estrogen and proges­
terone for 20 days to induce lobule-alveolar development equivalent to 
that of late pregnancy. Various combinations of prolactin, hydrocorti­
sone, and growth hormone were given daily on days 21-23 to pituitary-
intact rats and to rats hypophysectomized on day 21. This procedure was 
designed to test the ability of the different treatments to stimulate 
lactogenesis in the experimentally developed mammary glands. The suc­
cess of a lactogenic response to the experimental treatment was deter­
mined by analysis of RNA, DNA, and nitrogen levels in the mammary glands. 
Another experimental procedure involved repeating some of the above 
treatments but administering estrogen and progesterone on days 21-23 along 
with the other hormones. This was done to examine the nature and extent 
of an inhibition of lactogenesis by ovarian steroids. 
The results given herein indicated the following: 
1. Saline placebo injections had a slight lactogenic effect, in­
creasing both DNA and RNA. 
2. In rats with intact pituitary glands, hydrocortisone was pri­
marily responsible for any hormonally induced increase in 
RNA, DNA, and nitrogen. 
3. In hypophysectomized rats hydrocortisone had no effect on mam­
mary DNA by itself but when combined with growth hormone or 
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prolactin, DNA levels were higher than controls. The combina­
tion with prolactin seemed to have more effect. Neither pro­
lactin or growth hormone given individually affected mammary DNA. 
In hypophysectomized rats hydrocortisone alone effected a 
higher RNA level than the control. Prolactin or growth hormone 
potentiated this effect of hydrocortisone but had no effect when 
given alone. The combination of all three hormones yielded the 
greatest level of RNA in hypophysectomized treatment groups. 
No effect on nitrogen levels was observed with any combination 
of hydrocortisone, prolactin, or growth hormone given to hypophy­
sectomized rats. 
Estrogen and progesterone administered with any hormone treat­
ment to pituitary-intact rats caused a complete inhibition of 
any lactogenic response. Not only was RNA and nitrogen in­
hibited, but the increased synthesis of DNA was also inhibited. 
Administering estrogen and progesterone to hypophysectomized 
rats produced little effect. However, the results were considered 
inconclusive because of the small number of experimental animals. 
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APPENDIX 
Kemoval of Lipids from Mammary Glands 
1. Immediately after removal of the six abdominal-inguinal mammary 
glands they are immersed in 50 ml of a solution of chloroform and 
methanol (2;1 by volume). 
2. The tissue is then minced with a scissors and kept in chloroform/ 
methanol solution for 12 hours under constant mild agitation. 
3. The solvent is poured off and fresh chloroform/methanol (50 ml) is 
added to the minced tissue for another 12 hour extraction, again 
keeping under mild agitation. 
4. The chloroform/methanol is decanted off and ethyl ether (50 ml) 
is added to the minced tissue. Extract for 12 hours with agitation. 
5. Pour off the ether and add a final 50 ml of ether and extract for 
another 12 hours under agitation. 
6. Pour off the ether and allow to air dry over night. 
7. Place the dried fat-freed tissue(DFFT) in an oven at 50°C for two 
days, then place in a desiccator until ready for weighing. 
8. After the DFFT has been weighed, it is ground to a fine powder 
using a Wiley mill equipped with a number 40 sieve. 
9. The powdered DFFT is placed in an oven, again at 50°C for two days 
to insure dryness and then placed in a desiccator until ready for 
weighing samples for analysis. 
NOTE; Extraction times are not at all critical, change solutions in the 
morning and evening. Be sure DFFT powder is dry before weighing. 
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Extraction of Total Nucleic Acid 
1. 25 mg samples of DFFT are placed in thick walled, 12 or 15 ml vol­
umetric centrifuge tubes. About 4,5 ml-5 ml of 5% trichloroacetic 
acid (TCA) is added to each tube. 
2. Allow the material to stand for a couple of hours until all the 
tissue is saturated. Gently tapping the tubes will cause the 
saturated tissue to fall to the bottom. 
3. The tubes are then placed in a 90°C water bath for exactly 15 minutes. 
The tubes should be covered with glass marbles to reduce loss by 
evaporation. 
4. After removing the tubes from the water bath, they are immediately 
placed in a cold water bath. 
5. When cooled the tubes are centrifuged for 10-15 minutes at 3-4000 rpm. 
6. The supernatant is poured into another volumetric centrifuge tube 
or 10 ml volumetric flask. 
7. The residue is resuspended with 4.5 ml-5 ml of 5% TCA, placed in a 
90°C water bath for exactly 15 minutes, and cooled as before. 
8. This second digest is centrifuged, and the decant combined with 
the decant from the first extraction. 
9. The combined extracts are then brought up to a volume of 10 ml 
with 5% TCA. 
10. The extracts are placed in glass culture tubes for storage under re­
frigeration, until ready for analysis. 
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Preparation of Stock Hydrolyzed DNA and RNA Solutions 
Stock solutions of hydrolyzed DNA and RNA are prepared containing 
a concentration of 1 mg/ml. From these, dilutions can be made for de­
terminations of standard curves. The best procedure for preparing these 
is as follows; 
1. Place about 80 ml of 57„ TCA in a 250 ml glass beaker. Put a teflon 
coated magnetic stirring bar in the beaker. 
2. Cover the top of the beaker with a double layer of thick aluminum 
foil. Poke a small hole in the center of the foil and insert a 
thermometer through the hole into the fluid. Place the thermometer 
at an angle so that it will not interfere with the stirring bar. 
3. Place this apparatus on a heated magnetic stirrer and heat the TCA 
solution to exactly 90°C. (Make sure you can maintain this temperature 
fora period of 15 minutes.) 
4. Pour 100 mg of DNA or RNA into the hot stirring TCA. After exactly 
15 minutes from the time you put in the nucleic acid, the beaker is 
removed and placed in a cold water bath. 
5. The solution is then put into a 100 ml volumetric flask and filled 
to volume with 57„ TCA. This stock can be stored under refrigeration 
for up to six months. 
6. To more accurately determine the concentration of these hydrolyzed 
standards a phosphorus content is determined as described in the 
Appendix. 
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Colorimetric Determination of DNA Content 
Preparation of reagents 
1. Dlphenylamine reagent 
This reagent should be prepared on the day it is to be used. Into 
100 ml of A. R. glacial acetic acid (Baker's) is dissolved 1.5 g of 
reagent grade diphenylamine (use only Matheson, Coleman and Bell), 
and 1.5 ml of concentrated H2S0^. Just before use add 0.5 ml of 
aqueous acetaldehyde (16 mg/ml) to the reagent. 
2. Standard hydrolyzed DNA solutions 
From the prepared stock hydrolyzed DNA solution make at least five 
different dilutions, the largest containing no more than 500 ug of DNA. 
3. IN perchloric acid 
Add 9 ml of concentrated (70%) perchloric acid to 91 ml of glass dis­
tilled water. 
Method of color development 
1. 1 ml aliquots of nucleic acid extracts, as well as standards, are 
placed in test-tubes. To each tube is added 1 ml of IN perchloric 
acid and 4 ml of diphenylamine reagent. 
2. A blank is prepared by combining 1 ml of 5% TCA with 1 ml of IN 
perchloric acid and 4 ml of diphenylamine reagent. 
3. Color is developed by incubating in a water bath at 30°C for 16-20 
hours. 
4. The absorbance is measured at 600 mu. 
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Calculations 
A standard curve is prepared by plotting the optical densities of 
the five DNA standards against their concentrations. From this, the 
concentration of DNA in each of the extracts can be determined. Since 
standards and extracts were treated the same, no dilution corrections 
are necessary. 
Colorimetric Determination of RNA Content 
Preparation of reagents 
1. Orcinol reagent 
Orcinol should be a white crystalline product. Only orcinol pur­
chased from Calbiochem was found suitable for use without purifica­
tion. 
A solution of 0.5 g of FeCl^ per 100 ml of concentrated HCl is 
prepared, which can be stored indefinitely. Immediately before 
use, 1 g of orcinol is added per 100 ml of solution. 
2. Standard dilutions of both the hydrolyzed DNA and RNA stock solutions 
are required. Have five dilutions of each, the largest dilution 
having no more than 500 ug DNA or RNA. 
Method of color development 
1. 0.5 ml aliquots of nucleic acid extracts, as well as 0.5 ml aliquots 
of both DNA and RNA standards, are placed in test-tubes. To each 
test-tube is added 2 ml of 57» TCA and 2.5 ml of orcinol reagent. 
2. A blank is prepared by mixing 3 ml of 5% TCA with 3 ml of orcinol 
reagent. (Sufficient blank must be made to fill two cuvettes, in 
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order to zero-in the spectrophotometer). 
3. Place tubes in a hot water bath (95°G) for exactly 20 minutes. 
Have marbles on the tubes to prevent loss from evaporation, 
4. Cool the tubes in a cold water bath, 
5. The absorbance is measured at 660 mu. 
Calculations 
Two standard curves must be prepared; one for the DNA standards and 
one for the RNA standards. Orcinol reacts with DNA as well as RNA, 
although to a much lesser extent. Nevertheless, in each sample a cor­
rection must be made for the fraction of the total optical density 
measured which was due to the presence of DNA in the extract. This is 
done as follows: 
1. A standard curve is prepared plotting the optical densities of 
the DNA standards against their concentrations. 
2. Having previously determined DNA by the dipheny1amine method, 
the amount of DNA present in each of the 0.5 ml aliquots can 
be calculated. This means a separate calculation must be made 
for each sample. 
3. From the above standard curve it can be determined how much 
optical density will result from the amount of DNA in the aliquot. 
4. This calculated optical density due to DNA must be subtracted 
from the total optical density obtained from the spectrophoto­
meter. The remaining optical density, then, is that due to the 
RNA present in the 0.5 ml aliquot. (The "corrected" optical 
density.) 
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5. A standard curve is made plotting optical density of the RNA 
standards against their concentration. 
6. Using this standard curve the concentration of RNA in each 
sample can be determined from the "corrected" optical densities. 
Microdetermination of Kjeldahl Nitrogen 
Reagents 
1. Digestion mixture 
The following chemicals are combined in the order given; Potassium 
sulfate, 40 g, selenium oxychloride, 2 ml, water to 250 ml, and 
sulfuric acid, 250 ml, NOTEJ]' DO THIS UNDER A HOOD; WEAR LONG 
RUBBER GLOVES; WEAR PROTECTIVE GOGGLES, THIS MIXTURE IS EXTREMELY 
TOXIC AND CAN BE INHALED OR ABSORBED THROUGH THE SKIN, 
2. Ness1er reagent 
This reagent was obtained from Fischer Chemicals, 
3. Nitrogen standard solutions 
1.179 g of ammonium sulfate, previously dried for several days in a 
desiccator, is dissolved in 250 ml of 0.2N sulfuric acid. This gives 
a final concentration of 1000 r of nitrogen per ml. 
Digestion apparatus 
A pan about 2' x 1' and 5 cm deep is filled with sand and covered 
with a hard asbestos sheet into which rows of holes are drilled to support 
the digestion tubes (15x125 mm test-tubes). The pan is placed on a large 
hot plate, about the same size as the pan. When digesting, this apparatus 
should be UNDER THE HOOD. 
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Method of digestion 
1. Into each digestion tube a 5 mg sample of DFFT is placed, and 0.2 
ml of the digestion mixture (AGAIN...WEAR RUBBER GLOVES.) 
2. The tubes are embedded to a depth of about 2-3 cm in the sand. 
3. Three tubes were filled with 0.2 ml of sulfuric acid and a 400°C 
thermometer placed in the tubes. These tubes are embedded in center 
and ends of the pan. 
4. The hot plate is turned on, and when the thermometers read 310°C, 
the plate is adjusted to hold this temperature. The tubes are heated 
for one hour at this temperature. The volume of each tube is now 0.1 
ml. 
Method of color development 
1. The contents of each tube is diluted to 20 ml with glass distilled 
water, and mixed well. 
2. 0.5 ml aliquotes of the diluted digest are transferred to test-
tubes. 3.5 ml of glass distilled water and 1 ml of the Nessler re­
agent is added. Thorough mixing should follow each addition. 
3. Since the color is stable for only a little over an hour, only 40 
samples at a time should be mixed with the Nessler reagent. 
4. A blank is prepared by mixing 8 ml of water with 2 ml of Nessler 
reagent. 
5. The absorbance is measured at 500 mu. 
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Calculations 
A standard curve is prepared plotting nitrogen concentration of the 
standards against their optical density. The nitrogen content of the 
0.2 ml aliquot is determined from this. 
Procedure for the Analysis of Nucleic Acid Content by 
Colorimetric Determination of Phosphorus 
Preparation of reagents and solutions 
1. Standard phosphate 
A stock solution of monopotassium phosphate is made which contains 
80 ug of phosphorus per ml. Into a liter volumetric flask dissolve 
0,3509 g of monopotassium phosphate in water, add 10 ml of 10 N 
sulfuric acid, and dilute to the mark with distilled water. (It 
is suggested that glass distilled water be used throughout the pro­
cedure.) Make four dilutions from the stock; 40 ug/ml, 20 ug/ml, 
10 ug/ml, 5 ug/ml. 
2, Molybdate (ACID) reagent. 
Dissolve 25 g of ammonium molybdate in 200 ml distilled water. Rinse 
into a liter volumetric flask containing 500 ml of 10 N sulfuric 
acid, and dilute to mark with water. Store in a wax lined bottle 
under refrigeration. 
3. Molybdate reagent 
Dissolve 25 g of ammonium molybdate in a liter of distilled water. 
Store in a wax lined bottle under refrigeration, 
3, Amino-napthol-sulfonic acid reagent (ANS) 
This reagent can be bought pre-mixed in dry form from Harleco 
99 
(Hartman-Leddon Company), item number 52532. Prepare according to 
manufacturer's instructions. 
5, Sulfuric acid 
Prepare stock solutions of 5 N and 10 N. 
Determination of standard curve 
Color development of the standard phosphate solutions is carried out 
in 50 ml volumetric flasks according to the following procedures; 
1. Add 5 ml of standard phosphate solution. 
2. Add 30 ml of distilled water. 
3. Add 5 ml of molybdate (ACID) reagent, 
4. Add 2 ml of ANS reagent. 
5. Mix—dilute to mark with water--mix again, 
6. Let stand for 5 minutes and immediately measure against a blank 
at 700 mu. 
A blank is prepared in exactly the same way, except that the 5 ml of 
standard phosphate is replaced by another 5 ml of distilled water. 
From this, a standard curve relating phosphorus concentration to 
absorbance can be made. 
Determination of nucleic acid phosphorus content 
Assuming DNA and RNA standards have been prepared by hydrolysis in 
5% TCA, the procedure for determining phosphorus content is outlined as 
follows; 
1. Into a large lipped Pyrex test-tube (200 mm x 25 mm) add 5 ml of 
the stock nucleic acid solution to 5 ml of 5 N sulfuric acid. 
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2. Put about three glass boiling beads in the mixture and boil under a 
microburner. When the solution has boiled down to about a milli­
liter or two, a dense fume will appear and the solution turns yellow. 
When this occurs, turn the flame down low but do not let the boiling 
stop. The solution will get progressively darker and when there is 
no further blackening, add one drop of nitric acid so that it runs 
down the wall of the test-tube. This should eliminate most of the 
color. Add another drop if necessary, but do not add an excess. 
Continue boiling for about 30 seconds to remove all the nitric acid. 
3. Remove from heat and allow it to cool down slightly; then put it 
under the tap to further cool it. 
(Caution) This procedure should be performed under the hood. If at any­
time the solution stops boiling, turn up the flame slightly 
while agitating the solution until boiling again begins. If 
you do not agitate, it will superheat and spurt out. 
4. Empty the contents into a 50 ml volumetric flask. Wash the test-tube 
three times with 10 ml of distilled water per washing. Pour the 
washing into the flask. 
5. Add 5 ml of molybdate reagent and 2 ml of ANS reagent. 
6. Mix—fill to volume—mix. 
7. Let stand for 5 minutes, then immediately measure the absorbance 
against a blank at 700 mu . 
A blank is prepared by mixing the same reagents, replacing the 5 ml of 
nucleic acid solution with 5 ml of 5% TCA. The boiling procedure can be 
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eliminated. 
Comparison of the absorbance measured in the nucleic acid solution vdth 
the standard curve will give the concentration of phosphorus. Concen­
trations of DNA and RNA can then be estimated by assuming that phos­
phorus is 10% of the weight of the nucleic acid. 
Histological Check for the Presence of Pituitary Tissue 
Removal and fixing of tissue 
1. The top of the skull is removed and the brain taken out intact. 
A large area of the lower skull containing the sela tursica is dis­
sected from the whole skull and placed in 10% buffered formalin 
overnight. 
2. Now the tissue is hardened and easier to work with. Using a sharp 
scalpel, the tissue between the two trigeminal nerves is dissected 
from the sela tursica, washed in 50% ethanol, and stored in 70% ethanol. 
Materials needed for embedding 
1. Tertiary butyl alcohol (TEA) 
2. Four different combinations of TEA, ethanol (ETH), and water in the 
following proportions; 
A) 2 TBA/5 ETH/3 H^O 
B) 7 TBA/10 ETH/3 H^O 
C) 11 TBA/8 ETH/1 HgO 
D) 3 TBA/1 ETH/O H2O 
3. Melted Paraplast. 
4. A solution, half and half, of TBA and Paraplast. 
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Procedure for embedding 
1. Place the tissue in each of the solutions of TBA/ETH/H2O in the 
sequence A-D for a half hour in each solution. 
2. After solution D the tissue is placed in pure TEA for a half hour. 
3. The tissue is transferred to the paraplast-TBA solution and kept in 
the warming oven for 1 hour. 
4. Now the tissue is placed in pure paraplast and put in a vacuum oven 
for half an hour. 
5. Put the tissue in fresh paraplast and another half hour in the vacuum 
oven, then it is ready to embed. 
6. The embedded tissues are sectioned at 15 microns, and placed on slides. 
Materials needed for staining 
1. Iron alum 
5 g of ferric ammonium sulfate is added to 100 ml of distilled water. 
2. Harris hematoxylin 
3. Orange G solution 
2 g of orange G and 5 g of phosphotungstic acid is dissolved in 100 ml 
water. Put on a shaker overnight. Centrifuge (2000 rpm) and decant 
the clear supernatant. 
4. Schiff's leuco-fuchsin 
1 g of basic fuchsin is added to 200 ml of distilled water. Boil for 
5 minutes, then cool to 50°C. Add 20 ml of IN HCl, and 2 g potassium 
metabisulfite. Shake during the day and let stand overnight. Add 
0.5 g activated charcoal, shake and filter. Store in refrigerator when 
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not in use. The solution should remain colorless; if it starts 
to turn pink, try cooling it in the refrigerator. 
Procedure for staining 
1. Put slides in xylene, two changes, a couple of minutes each until 
all the paraplast is removed. 
2. Bring to water with a descending alcohol series; Absolute, 95%, 85%, 
70%, 50%, distilled water, about a minute in each alcohol. 
3. Periodic acid...15 minutes. 
4. Wash 5 times in distilled H^O. 
5. Schiff's reagent...30 minutes. 
6. Wash in running tap water 30 minutes. Rinse in distilled water. 
7. Iron Alum...1 minute. 
8. Wash 3 times in distilled water. 
9. Harris hematoxylin...1 minute. 
10. Wash 5 times in distilled water. 
11. Harris hematoxylin (second time)...l minute. 
12. Wash 5 times in distilled water. 
13. Orange G...5 minutes. 
14. Wash in running tap water...1 minute. 
15. 70% alcohol; 85%; 95%; two changes absolute,,.l minute each. 
16. Clear in xylene and mount in clearmount. 
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Preparation of Hormones for Injection 
Estradiol benzoate and Progesterone (E and P) 
A stock solution of estradiol benzoate in corn oil (1 mg/ml) is 
prepared first. Then an aliquot of this is added to progesterone and 
dissolved in corn oil. 
1. 5 ml of benzyl alcohol (a preservative) is placed in a 100 ml 
volumetric flask which is filled to volume with corn oil. 
2. 100 mg of estradiol benzoate is placed in a 250 ml wide-mouth 
volumetric flask with a magnetic stirring bar (teflon coated). 
3. Add the measured corn oil-benzyl alcohol carrier to the flask and 
stir until completely clear. 
(Since the usual injected concentration is 1 or 2 ug/ml there is 
enough stock solution here to last for years.) 
4. Into a 100 ml volumetric flask add; the required aliquot of the 
estradiol stock, 5 ml of benzyl alcohol, and corn oil to volume. 
Mix well. 
5. Add the needed amount of progesterone to a 250 ml wide-mouth flask. 
Add the measured corn oil-estradiol-benzyl alcohol solution just 
mixed. Put in a teflon coated magnetic stirring bar. 
6. Now place the 250 ml flask with its contents on the magnetic stirrer. 
The progesterone takes a long time to dissolve. To dissolve faster 
place a light bulb (75 watt) near the flask to warm the oil to 40°C--
do not allow it to get much higher. This should allow the progester­
one to dissolve in a couple of hours. 
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7. When the solution is completely clear, put a cork stopper (do not 
use rubber) on the flask and keep the preparation stored in this 
wide mouth flask. (The viscous oil does not go through a syringe 
needle easily. Therefore, it is necessary to remove the needle when 
filling the syringe; this is where the wide mouth flask comes in handy.) 
8. If the solution contains more than 4 mg per ml it becomes super­
saturated and the progesterone will crystallize out. This can be pre­
vented by keeping a light bulb near the solution to keep it at 
about 35-40°C. 
Pituitary hormones; Prolactin (P) or Growth Hormone (G) 
Although these hormones are generally supplied in bulk, since their 
potency decreases a week after they are dissolved in saline, it is best 
to prepare them in small quantities, usually 50 mg at a time. Prolactin 
and growth hormone received from NIH is insoluble in saline. Therefore, 
slightly alkaline saline (use NAOH) is prepared (pH - 9.0-9.5). The 
hormone is dissolved in a small amount of the alkaline saline, carefully 
neutralized (HCL), and filled to volume with saline, (This procedure is 
a bit difficult since the total volume is usually only 5-10 ml.) 
Hydrocortisone acetate (HCA) 
1. The suspending medium is first mixed. Add 1 drop of Tween 80 per 
five ml of saline. Add benzyl alcohol as a preservative; 0.9 ml 
per 100 ml of the saline mixture. 
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Hydrocortisone is placed in a tissue grinder and a small portion 
of the required volume of suspending medium is added. The HCA 
is then ground until all is in suspension (about 15 minutes to a 
half-hour). 
The suspension is then poured into a storage bottle. The tissue 
grinder is washed several times with the remaining suspending medium, 
and the washings added to the storage bottle. 
